Halofuginone analogs for inhibition of tRNA synthetases and uses thereof

Details for Australian Patent Application No. 2009282480 (hide)

Owner President and Fellows of Harvard College

Inventors Keller, Tracy; Mazitschek, Ralph; Whitman, Malcolm; Lee, Jinbo

Agent Davies Collison Cave

Pub. Number AU-A-2009282480

PCT Pub. Number WO2010/019210

Priority 61/153,866 19.02.09 US; 61/188,740 11.08.08 US

Filing date 11 August 2009

Wipo publication date 18 February 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/019210 Priority application(s): WO2010/019210

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282481-Compositions and methods for influencing satiety, lipid metabolism, and fat utilization

2009282478-Flavin derivatives